Integer Holdings Corporation (NYSE:ITGR – Get Free Report) insider Kirk Thor sold 11,767 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total value of $1,485,348.41. Following the completion of the sale, the insider directly owned 7,153 shares of the company’s stock, valued at approximately $902,923.19. This trade represents a 62.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Integer Stock Up 0.0%
Integer stock opened at $126.35 on Friday. The company’s 50 day simple moving average is $117.59 and its 200 day simple moving average is $98.67. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $126.79. The firm has a market capitalization of $4.30 billion, a price-to-earnings ratio of 34.52, a PEG ratio of 2.40 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.
Integer (NYSE:ITGR – Get Free Report) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm had revenue of $464.11 million during the quarter, compared to the consensus estimate of $451.07 million. During the same quarter in the prior year, the firm earned $1.55 earnings per share. The business’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current year.
Institutional Investors Weigh In On Integer
Analyst Upgrades and Downgrades
ITGR has been the subject of a number of recent analyst reports. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. HC Wainwright reissued a “buy” rating on shares of Integer in a research note on Friday, July 24th. Freedom Capital downgraded Integer from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a report on Monday. Finally, Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $109.86.
View Our Latest Research Report on ITGR
About Integer
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
Further Reading
- Five stocks we like better than Integer
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
